Efficacy of low-density-lipoprotein lowering with statins
Leufkens, H.G.; Herings, R.M.; Urquhart, J.
Lancet 344(8923): 683-684
1994
ISSN/ISBN: 0140-6736 PMID: 7915368 Document Number: 422828
Document emailed within 1 workday
Related Documents
2015: Switching from high-efficacy lipid-lowering therapies [atorvastatin or rosuvastatin] to simvastatin and the results on low-density lipoprotein cholesterol level Journal of the Medical Association of Thailand 98(1): 21-25Matsuda, Y. 1993: High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation Kobe Journal of Medical Sciences 39(1): 1-14
SoRelle, R. 2002: ATP III calls for more intensive low-density lipoprotein lowering in target groups Circulation 106(25): E9068
Oida, K.; Nakai, T.; Tamai, T.; Kutsumi, Y.; Kobayashi, T.; Hayashi, T.; Yamada, S.; Takeda, R. 1982: Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia Artery 10(4): 266-285
Konstantinov, V.O. 2017: The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications Kardiologiia 57(5): 68-72
Praipaisarnkit, K.; Wongpraparut, N.; Pongakasira, R. 2014: Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic Journal of the Medical Association of Thailand 97(Suppl 3): S147-S154
Masquelier, M.; Vitols, S.; Peterson, C. 1986: Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice Cancer Research 46(8): 3842-3847
Pearson, T.A.; Laurora, I.; Chu, H.; Kafonek, S. 2000: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Archives of Internal Medicine 160(4): 459-467
Nimkuntod, P.; Tongdee, P. 2015: Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis Journal of the Medical Association of Thailand 98(Suppl 4): S58-S63
Weis, S.; Kudchodkar, B.J.; Clearfield, M.B.; Lacko, A.G. 1992: The efficacy of gemfibrozil therapy for raising high density lipoprotein levels Artery 19(6): 353-366
Sathavarodom, N.; Boonyavarakul, A. 2010: Apolipoprotein B level in patients with type 2 diabetes who achieved goal of low density lipoprotein cholesterol and non-high density lipoprotein cholesterol Journal of the Medical Association of Thailand 93(Suppl 6): S166-S172
Wongtiraporn, W.; Wattanamongkonsil, L.; Kiartivich, S.; Mingvivat, N.; Thanakhumtorn, S.; Opartkiattikul, N.; Thamlikitkul, V. 2006: Utilization of calculated low density lipoprotein cholesterol and measured low density lipoprotein cholesterol in Siriraj Hospital Journal of the Medical Association of Thailand 89(Suppl 5): S156-S163
Li, Z.; Tao, Y.; Huang, J.; Wang, Q.; Zhang, D.-h.; Wu, X.-y. 2013: The characteristics of high density lipoprotein cholesterol and the relationship between high density lipoprotein cholesterol and the severity of coronary artery lesions in young men with acute myocardial infarction Zhonghua Yi Xue Za Zhi 93(19): 1458-1462
Kwiterovich, P.O. 2001: Safety and efficacy of treatment of children and adolescents with elevated low density lipoprotein levels with a step two diet or with lovastatin Nutrition Metabolism and Cardiovascular Diseases: Nmcd 11(Suppl 5): 30-34
Laster, B.H.; Kahl, S.B.; Popenoe, E.A.; Pate, D.W.; Fairchild, R.G. 1991: Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture Cancer Research 51(17): 4588-4593
Guo, Y.-f.; Hu, D.-y. 2007: Statins in lowering cholesterol in the elderly Zhonghua Nei Ke Za Zhi 46(11): 893-894
Scheen, A.J.; Sadzot, B. 2005: Which indications for statins besides their cholesterol-lowering effect? Revue Medicale Suisse 1(30): 1954; 1956-1959
Eriksson, M. 1998: Statins have other beneficial properties besides their cholesterol lowering effect Lakartidningen 95(35): 3670-3672
Einecke, D. 2003: First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis MMW Fortschritte der Medizin 145(51-52): 38
Monahan, L.K.; O'Kell, R.T.; Elliott, J.R. 1975: Low density lipoprotein cholesterol (CLDL) and lipoprotein phenotyping American Journal of Medical Technology 41(8): 307-309